NCT02009618View on ClinicalTrials.gov

The Effects of Rifaximin Therapy in Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
IBS
Interventions
DRUG

Rifaximin

Rifaximin tablet is given as 200 mg 3x2/daily, for 10 days.

DRUG

placebo

Trial Locations (1)

34093

Bezmialem Vakıf University, Gastroenterology Clinic, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT02009618 - The Effects of Rifaximin Therapy in Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter